Molecular mechanisms and proposed targets for selected anticancer gold compounds
- PMID: 22039866
- DOI: 10.2174/156802611798040732
Molecular mechanisms and proposed targets for selected anticancer gold compounds
Abstract
Nowadays, gold compounds constitute a family of very promising experimental agents for cancer treatment. Indeed, several gold(I) and gold(III) compounds were shown to manifest outstanding antiproliferative properties in vitro against selected human tumor cell lines and some of them performed remarkably well even in tumor models in vivo. Notably, the peculiar chemical properties of the gold centre impart innovative pharmacological profiles to gold-based metallodrugs most likely in relation to novel molecular mechanisms. The precise mechanisms through which cytotoxic gold compounds produce their biological effects are still largely unknown. Within this frame, the major aim of this review is to define the possible modes of action and the most probable biomolecular targets for a few representative gold compounds on which extensive biochemical and cellular data have been gathered. In particular, we will focus on auranofin and analogues, on gold(III) porphyrins and gold(III) dithiocarbamates. For these three families markedly distinct molecular mechanisms were recently invoked: a direct mitochondrial mechanism involving thioredoxin reductase inhibition in the case of the gold(I) complexes, the influence on some apoptotic proteins--i.e. MAPKs and Bcl-2--for gold(III) porphyrins, and the proteasome inhibition for gold(III) dithiocarbamates. In a few cases the distinct mechanisms may overlap. The general perspectives for the development of new gold compounds as effective anticancer agents with innovative modes of action are critically discussed.
Similar articles
-
Protein targets for anticancer gold compounds: mechanistic inferences.Anticancer Agents Med Chem. 2011 Dec;11(10):929-39. doi: 10.2174/187152011797927607. Anticancer Agents Med Chem. 2011. PMID: 21864237 Review.
-
Proteasome versus Thioredoxin Reductase Competition as Possible Biological Targets in Antitumor Mixed Thiolate-Dithiocarbamate Gold(III) Complexes.Inorg Chem. 2018 Sep 4;57(17):10832-10845. doi: 10.1021/acs.inorgchem.8b01464. Epub 2018 Aug 17. Inorg Chem. 2018. PMID: 30117739
-
Latest insights into the anticancer activity of gold(III)-dithiocarbamato complexes.Anticancer Agents Med Chem. 2010 May;10(4):283-92. doi: 10.2174/187152010791162298. Anticancer Agents Med Chem. 2010. PMID: 20184554 Review.
-
Gold compounds as anticancer agents: chemistry, cellular pharmacology, and preclinical studies.Med Res Rev. 2010 May;30(3):550-80. doi: 10.1002/med.20168. Med Res Rev. 2010. PMID: 19634148 Review.
-
Gold(III)-dithiocarbamato complexes induce cancer cell death triggered by thioredoxin redox system inhibition and activation of ERK pathway.Chem Biol. 2007 Oct;14(10):1128-39. doi: 10.1016/j.chembiol.2007.08.016. Chem Biol. 2007. PMID: 17961825
Cited by
-
An anticancer gold(III)-activated porphyrin scaffold that covalently modifies protein cysteine thiols.Proc Natl Acad Sci U S A. 2020 Jan 21;117(3):1321-1329. doi: 10.1073/pnas.1915202117. Epub 2020 Jan 2. Proc Natl Acad Sci U S A. 2020. PMID: 31896586 Free PMC article.
-
Reactivity of Gold(I) Monocarbene Complexes with Protein Targets: A Theoretical Study.Int J Mol Sci. 2019 Feb 14;20(4):820. doi: 10.3390/ijms20040820. Int J Mol Sci. 2019. PMID: 30769823 Free PMC article.
-
Cyclic 5-membered disulfides are not selective substrates of thioredoxin reductase, but are opened nonspecifically.Nat Commun. 2022 Apr 1;13(1):1754. doi: 10.1038/s41467-022-29136-4. Nat Commun. 2022. PMID: 35365603 Free PMC article.
-
Gold (III) Derivatives in Colon Cancer Treatment.Int J Mol Sci. 2022 Jan 10;23(2):724. doi: 10.3390/ijms23020724. Int J Mol Sci. 2022. PMID: 35054907 Free PMC article. Review.
-
Studies on the Interaction between Poly-Phosphane Gold(I) Complexes and Dihydrofolate Reductase: An Interplay with Nicotinamide Adenine Dinucleotide Cofactor.Int J Mol Sci. 2019 Apr 11;20(7):1802. doi: 10.3390/ijms20071802. Int J Mol Sci. 2019. PMID: 30979096 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
